Avanos Medical (AVNS) Debt to Equity (2013 - 2026)

Avanos Medical has disclosed Debt to Equity across 13 years of filings, most recently posting $0.01 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.01, up 24.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.01 (up 24.45% YoY), and the FY2025 annual result was $0.01, up 113.8% from the prior year.
• Debt to Equity came in at $0.01 for Q1 2026 at Avanos Medical, up from $0.01 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.18 in Q4 2022 to a low of -$0.29 in Q2 2025.
• The 5-year median for Debt to Equity is $0.0 (2022), against an average of -$0.03.
• Across the five-year window, Debt to Equity tumbled 3163.79% in 2023 and jumped 137.62% in 2025, its largest moves.
• Avanos Medical's Debt to Equity stood at $0.18 in 2022, then slumped by 96.14% to $0.01 in 2023, then slumped by 1464.95% to -$0.09 in 2024, then soared by 113.8% to $0.01 in 2025, then climbed by 6.33% to $0.01 in 2026.
• The last three Debt to Equity figures came in at $0.01 (Q1 2026), $0.01 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.